These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 20855724)

  • 21. Effect of colistin exposure and growth phase on the surface properties of live Acinetobacter baumannii cells examined by atomic force microscopy.
    Soon RL; Nation RL; Harper M; Adler B; Boyce JD; Tan CH; Li J; Larson I
    Int J Antimicrob Agents; 2011 Dec; 38(6):493-501. PubMed ID: 21925844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolate.
    Machado D; Antunes J; Simões A; Perdigão J; Couto I; McCusker M; Martins M; Portugal I; Pacheco T; Batista J; Toscano C; Viveiros M
    J Med Microbiol; 2018 Jun; 67(6):740-749. PubMed ID: 29717972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.
    Martínez-Guitián M; Vázquez-Ucha JC; Odingo J; Parish T; Poza M; Waite RD; Bou G; Wareham DW; Beceiro A
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4375-9. PubMed ID: 27139471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii.
    Pelletier MR; Casella LG; Jones JW; Adams MD; Zurawski DV; Hazlett KR; Doi Y; Ernst RK
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4831-40. PubMed ID: 23877686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
    Haeili M; Kafshdouz M; Feizabadi MM
    Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation.
    Dafopoulou K; Xavier BB; Hotterbeekx A; Janssens L; Lammens C; Dé E; Goossens H; Tsakris A; Malhotra-Kumar S; Pournaras S
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1892-5. PubMed ID: 26666921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS.
    Deveson Lucas D; Crane B; Wright A; Han ML; Moffatt J; Bulach D; Gladman SL; Powell D; Aranda J; Seemann T; Machado D; Pacheco T; Marques T; Viveiros M; Nation R; Li J; Harper M; Boyce JD
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii.
    Boinett CJ; Cain AK; Hawkey J; Do Hoang NT; Khanh NNT; Thanh DP; Dordel J; Campbell JI; Lan NPH; Mayho M; Langridge GC; Hadfield J; Chau NVV; Thwaites GE; Parkhill J; Thomson NR; Holt KE; Baker S
    Microb Genom; 2019 Feb; 5(2):. PubMed ID: 30720421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lytic transglycosylase contributes to the survival of lipooligosaccharide-deficient, colistin-dependent Acinetobacter baumannii.
    Lee JY; Lee H; Park M; Cha CJ; Shin D; Ko KS
    Clin Microbiol Infect; 2019 Sep; 25(9):1156.e1-1156.e7. PubMed ID: 30790686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reinforcing Lipid A Acylation on the Cell Surface of Acinetobacter baumannii Promotes Cationic Antimicrobial Peptide Resistance and Desiccation Survival.
    Boll JM; Tucker AT; Klein DR; Beltran AM; Brodbelt JS; Davies BW; Trent MS
    mBio; 2015 May; 6(3):e00478-15. PubMed ID: 25991684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship Between Different Resistance Mechanisms and Virulence in
    Espinal P; Pantel A; Rolo D; Marti S; López-Rojas R; Smani Y; Pachón J; Vila J; Lavigne JP
    Microb Drug Resist; 2019 Jun; 25(5):752-760. PubMed ID: 30632884
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.
    Lin L; Tan B; Pantapalangkoor P; Ho T; Baquir B; Tomaras A; Montgomery JI; Reilly U; Barbacci EG; Hujer K; Bonomo RA; Fernandez L; Hancock RE; Adams MD; French SW; Buslon VS; Spellberg B
    mBio; 2012; 3(5):. PubMed ID: 23033474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
    Cai Y; Chai D; Wang R; Liang B; Bai N
    J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoters of Colistin Resistance in
    Nurtop E; Bayındır Bilman F; Menekse S; Kurt Azap O; Gönen M; Ergonul O; Can F
    Microb Drug Resist; 2019 Sep; 25(7):997-1002. PubMed ID: 30964377
    [No Abstract]   [Full Text] [Related]  

  • 35. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outer Membranes of Polymyxin-Resistant
    Jiang X; Yang K; Han ML; Yuan B; Li J; Gong B; Velkov T; Schreiber F; Wang L; Li J
    ACS Infect Dis; 2020 Oct; 6(10):2698-2708. PubMed ID: 32871077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.
    Cai Y; Li R; Liang B; Bai N; Liu Y; Wang R
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3998-9. PubMed ID: 20585134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.
    Beceiro A; Llobet E; Aranda J; Bengoechea JA; Doumith M; Hornsey M; Dhanji H; Chart H; Bou G; Livermore DM; Woodford N
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3370-9. PubMed ID: 21576434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii.
    Hood MI; Becker KW; Roux CM; Dunman PM; Skaar EP
    Infect Immun; 2013 Feb; 81(2):542-51. PubMed ID: 23230287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.